CVRx CFO Jared Oasheim to Step Down, Stay Until February 2027 as Advisor
CVRX•CVRx CFO Jared Oasheim will step down his role to pursue other opportunities, remaining until a successor is appointed and serving as advisor through February 2027. The company has initiated a search for his replacement and will maintain financial leadership continuity.
1. CFO Transition Announcement
Jared Oasheim, who has served as CFO of CVRx since 2015, will resign to pursue other professional opportunities. He will stay in his current role until a successor is named and continue advising the company through February 2027.
2. Leadership Legacy
Oasheim led CVRx through its 2015 initial public offering and established a disciplined finance organization that supports the company’s commercial growth and Barostim neuromodulation product rollout.
3. Succession Plan
The company has launched a formal search for a new CFO to ensure uninterrupted financial oversight. Interim financial management will be handled by existing finance executives until a permanent appointment is made.
4. Upcoming Conference Presentation
Kevin Hykes and Jared Oasheim will present at the Goldman Sachs 47th Annual Global Healthcare Conference on June 10, 2026, offering an opportunity to review CVRx’s commercial progress and financial outlook.
